Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis

Clinical Hemorheology and Microcirculation

Volumn 41, Issue 4, 2009, Pages 279-285

  Vayá, Amparo ^a   Martinez Triguero, Marisa ^a   Romagnoli, Marco ^b   López, María ^a   Ricart, Alicia ^c   Corella, Dolores ^d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Hemorheology; Upper extremity deep vein thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CHOLESTEROL; FIBRINOGEN; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTHROMBIN; PROTHROMBIN G20210A; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; LIPID;

ADULT; ARTICLE; BLOOD RHEOGRAPHY; BLOOD VISCOSITY; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; GENE MUTATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL CONTRACEPTION; PLASMA VISCOSITY; PROTEIN S DEFICIENCY; TRIACYLGLYCEROL BLOOD LEVEL; UPPER EXTREMITY DEEP VEIN THROMBOSIS; ARM; BLOOD; BLOOD RHEOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; VASCULARIZATION; VEIN THROMBOSIS;

ADULT; BODY MASS INDEX; FEMALE; HEMORHEOLOGY; HUMANS; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; UPPER EXTREMITY; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 65549164311     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1179     Document Type: Article

References (37)

1. F.A. Spencer, E.C. Lessard and R.J. Goldberg, For the Worcester Venous Thromboembolism Study, Am. J. Med. 120 (2007), 678-684.
2. G. Elliot, Upper-extremity deep vein thrombosis, Lancet 349 (1997), 1188-1189.
3. B. Linnemann, F. Meister, J. Schwonberg, M. Schindewolf, D. Zgouras and L. Lindhoff, MAISTHRO registry, Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry, Thromb. Haemost. 100 (2008), 440-446.
4. L.E. Flinterman, F.J.M. Van der Meer, F.R. Rosendaal and C.J.M. Doggen, Current perspective of venous thrombosis in the upper extremity, J. Thromb. Haemost. 6 (2008), 1262-1274.
5. A. Vayá, Y. Mira, J. Mateo, C. Falco, P. Villa, A. Estelles, Md. Corella, J. Fontcuberta and J. Aznar, Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk, Thromb. Haemost. 89 (2003), 452-457.
6. I. Martinelli, T. Battaglioli, P. Buciarelli, S.M. Passamonti and P.M. Manucci, Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities, Circulation 110 (2004), 566-570.
7. M. Ruggeri, G. Castaman, A. Tosseto and F. Rodeghiero, Low prevalence of thrombophilic coagulation defects in patients with deep vein thrombosis of the upper limbs, Blood Coagul. Fibrinolysis 8 (1997), 191-194.
8. P. Prandoni, P. Polistena, E. Bernardi, A. Cogo, D. Casara, F. Verlato, F. Angelini, P. Simioni, G.P. Signorini, L. Benedetti and A. Girolami, Upper extremity deep vein thrombosis, Arch. Intern. Med. 157 (1997), 57-62.
9. E. Héron, O. Lozinguez, M. Alhenc-Gelas, J. Emmerich and J.N. Fiessinger, Hypercoagulable states in primary upper-extremity deep vein thrombosis, Arch. Intern. Med. 160 (2000), 382-386.
10. M.H. Ellis, Y. Manor and M. Witz, Risk factors and management of patients with upper limb deep vein thrombosis, Chest 117 (2000), 43-46.
11. F.W.G. Leebeek, N.A.M. Stadhouders, D. van Stein, E.B. Gómez-García and M.C. Kappers-Klunne, Hypercoagulability states in upper-extremity deep venous thrombosis, Am. J. Hematol. 67 (2001), 15-19.
12. M.F. Hendler, S.S. Meschengieser, A.N. Blanco, M.F. Alberto, M.J. Salviú, L. Gennari and M.A. Lazzari, Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects, Am. J. Hematol. 76 (2004), 330-337.
13. J.W. Bloom, J.M. Doggen, S. Osanto and F.R. Rosendaal, Old and new risk factors for upper extremity deep vein thrombosis, J. Thromb. Haemost. 3 (2005), 2471-2478.
14. A. Vayá, C. Falcó, M. Simó, F. Ferrando, Y. Mira, J. Todolí, F. España and D. Corella, Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis, Thromb. Haemost. 98 (2007), 621-626.
15. G.D.O. Lowe, Rheological influences on thrombosis, Baillieres Clin. Haematol. 7 (1994), 573-589.
16. R. Balendra, A. Rumlev, M. Orr, S. Lennie, P. McColl and G.D.O. Lowe, Blood lipids, coagulation, fibrinolysis and rheology in spontaneous proven deep vein thrombosis, Brit. J. Haematol. 77(Suppl 1) (1991), 83.
17. R. Koppensteiner, M. Hofmann, M. Atteneder, E. Minar and H. Ehringer, Blood rheology in acute deep venous thrombosis. Follow up to one year after the acute event under conventional anticoagulant treatment, Clin. Hemorheol. 12 (1992), 495.
18. A. Chabanel, H. Horellou, J. Conard and M. Samama, Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment, Brit. J. Haematol. 88 (1994), 174-179.
19. A. Vaya, Y. Mira, M. Martinez, P. Villa, F. Ferrando, A. Estelles, D. Corella and J. Aznar, Biological risk factors for deep vein thrombosis, Clin. Hemorheol. Microcirc. 26 (2002), 41-53.
20. E. Alt, S. Banyai, M. Banyai and R. Koppensteiner, Blood rheology in deep venous thrombosis- relation to persistent and transient risk factors, Thromb. Res. 107 (2002), 101-107.
21. E. Krieger, B. van Der Loo, B.R. Amann-Vesti, V. Rousson and R. Koppensteiner, C-reactive protein and red cell aggregation correlate with late venous function after acute deep venous thrombosis, J. Vasc. Surg. 40 (2004), 644-649.
22. M. Frezzato, A. Tosetto and F. Rodeghiero, Validated questionnaire for the identification of previous personal or familial venous thromboembolism, Am. J. Epidemiol. 143 (1996), 1257-1265.
23. Guidelines for measurement of blood viscosity and erythrocyte deformability, International Committee for standardization in Haematology, Expert panel on blood rheology, Clin. Hemorheol. 6 (1986), 439-453.
24. F. Jung, H.G. Roggenkamp, R. Schneider and H. Kiesewetter, Das Kapillarschlauch-Plasmaviskosimeter. Ein neues Messgerät zur Quantifizierung der Blutplasmaviskosität, Biomed. Tech. 28 (1983), 249-252.
25. H. Schmid-Schönbein, E. Volger, P. Teitel, H. Kiesewetter, V. Daver and L. Heilmann, New hemorheological techniques for the routine laboratory, Clin. Hemorheol. 2 (1983), 93-105.
26. P. Ruef, J.M.B. Pöschl and O. Linderkamp, The rheodyn SSD for measuring erythrocyte deformability, Biorheology 32 (1995), 357-358.
27. S.M. Razavian, V. Atger, M. Giral, M. Cambillau, M. Del-Pino, A.C. Simon, N. Moatti and J. Levenson, Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemia men, Artherioscl. Thromb. 14 (1994), 361-366.
28. A. Vayá, M. Martinez, R. Carmena and J. Aznar, Red blood cell aggregation and primary hyperlipoproteinemia, Thromb. Res. 72 (1993), 119-126.
29. C. Falcó, A. Vayá, M. Simó, T. Contreras, M. Santaolaria and J. Aznar, Influence of fibrinogen levels on erythrocyte aggregation determined with the Myrenne aggregometer and the Sefam erythro-aggregometer, Clin. Hemorheol. Microcirc. 33 (2005), 145-151.
30. X. Weng, G.O. Roederer, R. Beaulieu and G. Cloutier, Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidaemic and hyperlipidaemic individuals, Thromb. Haemost. 80 (1998), 903-908.
31. A. Vayá, C. Falcó, E. Réganon, V. Vila, V. Martinez-Sales, D. Corella, M.T. Contreras and J. Aznar, Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction, Thromb. Haemost. 91 (2004), 354-359.
32. T.V. Korotaeva, N.N. Firsov, A. Bjelle and M.A. Vishlova, Erythrocytes aggregation in healthy donors at native and standard hematocrit: the influence of sex, age, immunoglobulins and fibrinogen concentrations. Standardization of parameters, Clin. Hemorheol. Microcirc. 36 (2007), 335-343.
33. O. Raz, O. Rogowski, I. Shapira, N. Maharshak, Y. Karni and S. Berliner, Dissociated effects of physical activity and weight loss on fibrinogen concentrations and markers of red blood cell aggregation. Relevance for life style modification in atherothrombosis, Clin. Hemorheol. Microcirc. 3 (2007), 253-262.
34. E. Sola, A. Vayá, D. Corella, M.L. Santaolaria, F. España, A. Estellés and A. Hernández-Mijares, Erythrocyte hyperag-gregation in obesity. Determining factors and weight loss influence, Obesity 15 (2007), 2128-2134.
35. A. Vaya, Y. Mira, F. Ferrando, M.T. Contreras, A. Estelles, F. España, D. Corella and J. Aznar, Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors, Brit. J. Haematol. 118 (2002), 255-259.
36. D. Lechner, C. Wiener, A. Weltermann, L. Eischer, S. Eichinger and P.A. Kyrle, Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence, J. Thromb. Haemost. 6 (2008), 1269-1274.
37. A. Vayá, Y. Mira, F. Ferrando, D. Corella and J. Aznar, Does obesity constitute a risk factor for upper-extremity deep vein thrombosis?, Thromb. Haemost. 94 (2005), 228-230.